Survivors (n = 38) | Non-survivors (n = 11) | P-value | |
---|---|---|---|
Sex, M/F | 37/1 | 11/0 | NA |
Age, yr | 40.97 ± 14.29 | 43.55 ± 16.48 | 0.684 |
Body mass index | 19.69 ± 2.648 | 20.90 ± 2.43 | 0.274 |
CD4+ cell count, cells/mm3(ul) | 59.28 ± 30.38 | 47.15 ± 28.71 | 0.387 |
D-dimer | 1314.34 ± 1697.91 | 5427.91 ± 8050.52 | 0.010 |
Albumin | 33.05 ± 5.26 | 25.37 ± 5.99 | 0.001 |
CRP | 39.88 ± 148.75 | 91.74 ± 56.27 | 0.007 |
ESR | 60.23 ± 25.96 | 66.00 ± 30.17 | 0.615 |
P/F ratio, mmHg | 398.34 ± 135.17 | 318.33 ± 106.62 | 0.144 |
LDH | 339.55 ± 148.75 | 543.38 ± 328.44 | 0.045 |
Kynurenine | 2.93 ± 2.19 | 4.32 ± 3.56 | 0.051 |
Tryptophan | 15.48 ± 3.13 | 15.54 ± 3.66 | 0.952 |
Kyn/Trp (mM/M) | 169.05 ± 72.40 | 275.91 ± 132.03 | 0.002 |
PaO2/FiO2 ≤ 300 mmHg, No. (%) | 9 (9/38) | 9 (9/11) | 0.001 |
Patients receiving ART, No. (%) | 6 (6/38) | 4 (4/11) | 0.201 |
Treatment for PCP | 38 | 11 | NA |